RK

Ranjan Kumar Sinha

Active Director Director DIN 10181874
DIN 10181874 First appointment May 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Ranjan Kumar Sinha

Data last updated:

Ranjan Kumar Sinha is a Director at Oorja Pharma Private Limited (since 2023). Oorja Pharma Private Limited reported revenue of ₹14.6 Lakh (FY 2025).

DIN 10181874
Primary Designation Director
First Appointment 29 May 2023
Oldest Company Age 3 yrs
Largest company Oorja Pharma Private Limited · ₹14.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Oorja Pharma Private Limited U47721JH2023PTC020613
Director29 May 20232023₹14.6 Lakh (FY 2025)Active

Board colleagues of Ranjan Kumar Sinha

NameDINCompanyDesignation
Anindya Banerjee10181875Oorja Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Oorja Pharma Private Limited
Premium access

Shareholding and investment profile for Ranjan Kumar Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjan Kumar Sinha

Ranjan Kumar Sinha currently holds 1 directorship: Oorja Pharma Private Limited (Director, since 29 May 2023, revenue ₹14.6 Lakh (FY 2025)).

Ranjan Kumar Sinha was first appointed on 29 May 2023 as Director at Oorja Pharma Private Limited.

The current boards of Ranjan Kumar Sinha's companies include Anindya Banerjee (Oorja Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available